2012 Annual Meeting | Non-Alzheimer's Dementia

Date Sunday 04/22/12

Time 09:00 AM - 01:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Michael D. Geschwind, MD, PhD, FAAN

Topic(s)

Learning Objectives Participants should understand the differential diagnosis, clinical, laboratory, and neuroimaging evaluation, and comprehensive management of the main categories of non-AD dementia.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic

Program Evaluations

Event Timeline
09:00 AM - 09:55 AM		Introduction/Rapidly Progressive and Autoimmune Dementias Michael D. Geschwind, MD, PhD, FAAN
09:55 AM - 10:45 AM		Frontotemporal and Related Dementias Bruce L. Miller, MD, FAAN
10:45 AM - 11:00 AM		Break
11:00 AM - 11:50 AM		Lewy Body Dementias James B. Leverenz, MD, FAAN
11:50 AM - 12:40 PM		White Matter Dementia Christopher M. Filley, MD, FAAN
12:40 PM - 01:00 PM		Questions and Answers

Faculty Disclosures
Christopher M. Filley, MD, FAAN	Dr. Filley has received personal compensation for serving as an employee of University of Colorado Press. Dr. Filley has received personal compensation for serving as an employee of Oxford University Press. Dr. Filley has received personal compensation for serving as an employee of Cambridge University Press . Dr. Filley has received personal compensation for serving as an employee of Elsevier, Inc.. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wheeler Trigg O'Donnell LLP. Dr. Filley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Evans Case LLP. The institution of Dr. Filley has received research support from Department of Defense. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care. Dr. Filley has received publishing royalties from a publication relating to health care.
James B. Leverenz, MD, FAAN	Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..

��ɫ��

��ɫ��